Daito Pharmaceutical Co Ltd (4577) Stock Price & News

4577:TYO

Daito Pharmaceutical Co Ltd

¥1,304.00

-1.51%

(-20.00) 1D

Nov 6, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4577...

Open

¥1,305

High

¥1,307

Low

¥1,285

Mkt. cap

37.63B

Avg. vol.

93.07K

Volume

308.00K

Dividend

3.07%

Quarterly dividend

¥10

Ex-dividend date

Nov 27, 2026

P/E ratio

11.94

52-wk high

¥1,521

52-wk low

¥1,120

EPS

¥109

Shares outstanding

12.51M

No. of employees

Open

¥1,305

High

¥1,307

Low

¥1,285

Mkt. cap

37.63B

Avg. vol.

93.07K

Volume

308.00K

Dividend

3.07%

Quarterly dividend

¥10

Ex-dividend date

Nov 27, 2026

P/E ratio

11.94

52-wk high

¥1,521

52-wk low

¥1,120

EPS

¥109

Shares outstanding

12.51M

No. of employees

Related stocks

2313

Compeq Manufacturing Co Ltd

NT$159.00

-3.93%

4526

Tongtai Machine & Tool Co Ltd

News stories

From web sources and news partners

Benzinga

13 minutes ago

Dow Jones and S&P 500 Outlook: Stock Market News To Watch This Week

Yahoo Finance

1 hour ago

Boeing (BA): A Top 10 Dow Stock for 2027 With a Record $745B of Orders

Yahoo Finance

1 hour ago

Coca-Cola (KO) Makes the Dow’s Low-Upside List While Selling More Drinks, Not Just Charging More

Barron's

7 hours ago

Housing vs. Stocks: Lowest Share of Home Buyers Since 2006 Say Real Estate Beats Equities

About Daito Pharmaceutical Co Ltd

CEO-

Employees1.08K

FoundedJun 30, 1942

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websitedaitonet.co.jp

All values in JPY	Nov 2025	Feb 2026	May 2026	Aug 2026
Revenue	12.13B	11.59B	13.92B	11.89B
Cost of goods sold	9.92B	9.24B	11.14B	9.70B
Cost of revenue	9.92B	9.24B	11.14B	9.70B
Research and development expenses	-	-	2.22B	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.58B	1.23B	-327.00M	1.48B
Operating expense	1.58B	1.23B	1.90B	1.48B
Total operating expenses	11.50B	10.46B	13.03B	11.18B
Operating income	627.00M	1.13B	884.00M	713.00M
Other non operating income	102.00M	-1.00M	30.00M	9.00M
EBT including unusual items	782.00M	1.44B	796.00M	962.00M
EBT excluding unusual items	789.00M	1.21B	917.00M	807.00M
Income tax expense	237.00M	387.00M	-71.00M	245.00M
Effective tax rate	30.31%	26.97%	-8.92%	25.47%
Other operating expenses	-	-	-	-
Net income	537.00M	1.03B	894.00M	700.00M
Net profit margin	4.43%	8.92%	6.42%	5.89%
Earnings per share	-	-	-	-
Interest and investment income	7.00M	29.00M	-	38.00M
Interest expense	-33.00M	-33.00M	-34.00M	-30.00M
Net interest expenses	-26.00M	-4.00M	-34.00M	8.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	1.69B	2.21B	1.98B	1.81B
Gain or loss from assets sale	-	-	-	-

Ask anything